UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Journal of rheumatology, 2009-03, Vol.36 (3), p.576

2009

Volltextzugriff (PDF)

Abstract 18803: Abnormal Right Ventricular Longitudinal Strain With Exercise Stress Echocardiography in Systemic Sclerosis

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A18803-A18803

2016

Volltextzugriff (PDF)

Abstract 19659: Early Detection of Right Ventricular Dysfunction Using Speckle-Tracking Echocardiography in Systemic Sclerosis Patients

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial

Arthritis & rheumatology (Hoboken, N.J.), 2022-08, Vol.74 (8), p.1399-1408

2022

Volltextzugriff (PDF)

Adipose-Derived Regenerative Cell Transplantation in Systemic Sclerosis: Scleroderma Treatment with Celution Processed Adipose Derived Regenerative Cells- a Randomized Clinical Trial

Arthritis & rheumatology (Hoboken, N.J.), 2022-03

2022

Volltextzugriff (PDF)

Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis

Arthritis care & research (2010), 2022-11, Vol.74 (11), p.1806-1812

2022

Volltextzugriff (PDF)

ANCA-associated vasculitis in scleroderma: A renal perspective

Clinical nephrology, 2018-12, Vol.90 (6), p.413

2018

Volltextzugriff (PDF)

Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Volltextzugriff (PDF)

Antiangiogenic plasma activity in patients with systemic sclerosis

Arthritis and rheumatism, 2007-10, Vol.56 (10), p.3448-3458

2007

Volltextzugriff (PDF)

Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis

The International Journal of Cardiovascular Imaging, 2021-07, Vol.37 (7), p.2137-2147

2021

Volltextzugriff (PDF)

Assessment of the Systemic Sclerosis–Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short‐Form Development

Arthritis care & research (2010), 2023-08, Vol.75 (8), p.1725-1734

2023

Volltextzugriff (PDF)

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Arthritis care & research (2010), 2017-11, Vol.69 (11), p.1764-1770

2017

Volltextzugriff (PDF)

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

International Journal of Rheumatology, 2011-01, Vol.2011, p.214013-7

2011

Volltextzugriff (PDF)

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry

International journal of rheumatic diseases, 2022-02, Vol.25 (2), p.163-174

2022

Volltextzugriff (PDF)

Biomarkers in Scleroderma: Progressing from Association to Clinical Utility

Current rheumatology reports, 2016-03, Vol.18 (3), p.17-17, Article 17

2016

Volltextzugriff (PDF)

Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study

Arthritis research & therapy, 2015-08, Vol.17 (1), p.201-201, Article 201

2015

Volltextzugriff (PDF)

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Volltextzugriff (PDF)

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Arthritis & rheumatology (Hoboken, N.J.), 2021-02, Vol.73 (2), p.315-323

2021

Volltextzugriff (PDF)

Cardiac complications of systemic sclerosis: recent progress in diagnosis

Current opinion in rheumatology, 2010-11, Vol.22 (6), p.696-703

2010

Volltextzugriff (PDF)

Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients

Annals of the rheumatic diseases, 2013-07, Vol.72 (7), p.1136-1140

2013

Volltextzugriff (PDF)

Clinical and Molecular Phenotyping in Scleromyxedema Pre- and Post-Treatment with Intravenous Immunoglobulin

Arthritis care & research (2010), 2020-05, Vol.72 (6), p.761-767

2020

Volltextzugriff (PDF)

Clinical and Molecular Phenotyping in Scleromyxedema Pretreatment and Posttreatment With Intravenous Immunoglobulin

Arthritis care & research (2010), 2020-06, Vol.72 (6), p.761-767

2020

Volltextzugriff (PDF)

Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

Arthritis & rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1328-1330

Hummers, Laura K.

2023

Volltextzugriff (PDF)

Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry

Clinical rheumatology, 2020-01, Vol.39 (1), p.93-102

2020

Volltextzugriff (PDF)

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation

Clinical and experimental rheumatology, 2023-08, Vol.41 (8), p.1632

2023

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(141)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(105)
Humans
(85)
Rheumatology
(85)
Female
(61)
Male
(56)
Middle Aged
(55)
Scleroderma
(53)
Adult
(46)
Systemic Sclerosis
(45)
Scleroderma, Systemic - Complications
(43)
Aged
(38)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Pulmonary Hypertension
(18)
Risk Factors
(18)
Hypertension, Pulmonary - Etiology
(17)
Patients
(17)
Scleroderma, Systemic - Diagnosis
(17)
Severity Of Illness Index
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Abstract 18803: Abnormal Right Ventricular Longitudinal Strain With Exercise Stress Echocardiography in Systemic Sclerosis

Abstract 19659: Early Detection of Right Ventricular Dysfunction Using Speckle-Tracking Echocardiography in Systemic Sclerosis Patients

Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial

Adipose-Derived Regenerative Cell Transplantation in Systemic Sclerosis: Scleroderma Treatment with Celution Processed Adipose Derived Regenerative Cells- a Randomized Clinical Trial

Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis

ANCA-associated vasculitis in scleroderma: A renal perspective

Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma

Antiangiogenic plasma activity in patients with systemic sclerosis

Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis

Assessment of the Systemic Sclerosis–Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short‐Form Development

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry

Biomarkers in Scleroderma: Progressing from Association to Clinical Utility

Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Cardiac complications of systemic sclerosis: recent progress in diagnosis

Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients

Clinical and Molecular Phenotyping in Scleromyxedema Pre- and Post-Treatment with Intravenous Immunoglobulin

Clinical and Molecular Phenotyping in Scleromyxedema Pretreatment and Posttreatment With Intravenous Immunoglobulin

Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation

Suchergebnisse filtern